Alain Katic is a Psychiatry physician affiliated with Clinical Trials of Texas. OpenAlex indexes 16 publications with 397 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6330 West Loop S Ste 650
Bellaire, TX 77401
Telephone
713-527-8448Registry record last updated 23 Jul 2018.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Supernus Pharmaceuticals, Inc.Program year202531 payments$17,766openpaymentsdata.cms.gov ↗
- Corium, LLCProgram year202527 payments
- Bausch Health US, LLCProgram year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
98.7%Benzodiazepine20.2%Alprazolam45%Clonazepam29%Diazepam18%Lorazepam8%Part D<11 patientsSSRI19.1%Trazodone Hcl33%Fluoxetine Hcl23%Sertraline Hcl20%Escitalopram Oxalate9%Citalopram Hbr8%Paroxetine Hcl6%Part D<11 patients+ 10 more classes in this area
Cardiovascular
1.3%Beta blocker1.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2.43 Viloxazine Extended-Release Capsules in Children and Adolescents With ADHD: Final Results of a Long-Term, Phase 3, Open-Label Extension Study
Journal of the American Academy of Child & Adolescent Psychiatry
2023 - Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder
The Primary Care Companion For CNS Disorders
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”